During the past decade, Piedmont Healthcare conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Piedmont Healthcare" #1 sponsor was "Actelion" with 4 trials, followed by "Bellerophon Pulse Technologies" with 1 trials sponsored, "Duke University" with 1 trials sponsored, "University of Michigan" with 1 trials sponsored and "Weill Medical College of Cornell University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Healthcare" #1 collaborator was "Pulmonary Fibrosis Foundation" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Three Lakes Foundation" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Healthcare" are "Pulmonary Arterial Hypertension" (2 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials), "Idiopathic Pulmonary Fibrosis (IPF)" (1 trials) and "Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease" (1 trials). Many other conditions were trialed in "Piedmont Healthcare" in a lesser frequency.

Most popular intervention types in "Piedmont Healthcare" are "Drug" (4 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Macitentan" (2 trials), "INOpulse®" (1 trials), "Macitentan 10 mg" (1 trials) and "Macitentan 37.5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Healthcare" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Healthcare". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Piedmont Healthcare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Healthcare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".